Faculty of Medicine and Health Sciences
72906 publications
Show
Sort by
-
Subcutaneous epcoritamab plus R-DHAX/C in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) eligible for autologous stem cell transplant (ASCT) : preliminary phase 1/2 results
-
- Journal Article
- A1
- open access
Inhibition of the protein arginine methyltransferase PRMT5 in high-risk multiple myeloma as a novel treatment approach
-
- Journal Article
- A1
- open access
Up to 8-year follow-up from RESONATE-2 : first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
-
Effect of prior therapy and disease refractoriness on the efficacy and safety of oral selinexor in patients with diffuse large B-cell lymphoma (DLBCL) : a post-hoc analysis of the SADAL study
-
Glofitamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and >= 2 prior lines of therapy : key results of the phase-II expansion
(2022) ONCOLOGY RESEARCH AND TREATMENT. In Oncology Research and Treatment 45(Supplement 2). p.50-51 -
Glofitamab for relapsed or refractory diffuse large B-cell lymphoma
-
Dementie als grondslag voor euthanasie
-
- Journal Article
- A1
- open access
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer : a study of the Chronic Malignancies Working Party of the EBMT
-
Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2, cohort B
-
- Miscellaneous
- open access
Correction : palliative care symptoms, concerns and well-being of older people with frailty and complex care needs upon hospital discharge : a cross-sectional study